Lucas G. de Moura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lucas G. de Moura has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Cristiano Faria Pisani
Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Brasil
2 shared publications - Mauricio Scanavacca
Universidade de São Paulo, Brasil
2 shared publications - Muhieddine Omar Chokr
Universidade de São Paulo, Brasil
2 shared publications - Vera Demarchi Aiello
Laboratory of Pathology, Heart Institute (InCor), University of São Paulo School of Medicine, São Paulo, Brazil
2 shared publications Andre A. L. Do Carmo
Hospital das Clínicas and Faculdade de Medicina Universidade Federal de Minas Gerais Belo Horizonte Brazil
1 shared publication- Arnobio Dias da Ponte
Antonio Prudente Hospital, Fortaleza, CE - Brasil
1 shared publication
Latest Publications
- Open Access
- 27 January 2021
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 116 (1) , 119-126
Ablação por Cateter de Taquicardia Atrial Focal com Ativação Precoce Próxima ao Feixe de His, a Partir da Cúspide Aórtica não Coronária
Resumo Fundamento A ablação da taquicardia atrial (TA) com local de ativação mais precoce próxima ao feixe de His é um desafio, devido ao risco de bloqueio de AV completo por sua proximidade ao sistema de His-Purkinje (SHP). Uma alternativa para minimizar esse risco é posicionar o cateter na cúspide não coronária (CNC), que é anatomicamente contígua à região para-Hissiana. Objetivos O objetivo deste estudo foi fazer uma revisão de literatura e avaliar as características eletrofisiológicas, a segurança e o [...] Resumo Fundamento A ablação da taquicardia atrial (TA) com local de ativação mais precoce próxima ao feixe de His é um desafio, devido ao risco de bloqueio de AV completo por sua proximidade ao sistema de His-Purkinje (SHP). Uma alternativa para minimizar esse risco é posicionar o cateter na cúspide não coronária (CNC), que é anatomicamente contígua à região para-Hissiana. Objetivos O objetivo deste estudo foi fazer uma revisão de literatura e avaliar as características eletrofisiológicas, a segurança e o
- 27 January 2021
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 116 (1) , 119-126
Open AccessAblação por Cateter de Taquicardia Atrial Focal com Ativação Precoce Próxima ao Feixe de His, a Partir da Cúspide Aórtica não Coronária
Resumo Fundamento A ablação da taquicardia atrial (TA) com local de ativação mais precoce próxima ao feixe de His é um desafio, devido ao risco de bloqueio de AV completo por sua proximidade ao sistema de His-Purkinje (SHP). Uma alternativa para minimizar esse risco é posicionar o cateter na cúspide não coronária (CNC), que é anatomicamente contígua à região para-Hissiana. Objetivos O objetivo deste estudo foi fazer uma revisão de literatura e avaliar as características eletrofisiológicas, a segurança e o [...] Resumo Fundamento A ablação da taquicardia atrial (TA) com local de ativação mais precoce próxima ao feixe de His é um desafio, devido ao risco de bloqueio de AV completo por sua proximidade ao sistema de His-Purkinje (SHP). Uma alternativa para minimizar esse risco é posicionar o cateter na cúspide não coronária (CNC), que é anatomicamente contígua à região para-Hissiana. Objetivos O objetivo deste estudo foi fazer uma revisão de literatura e avaliar as características eletrofisiológicas, a segurança e o
- 16 April 2020
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 31 (6) , 1413-1419
Catheter ablation of the parahisian accessory pathways from the aortic cusps—Experience of 20 cases—Improving the mapping strategy for better results
Introduction: Catheter ablation of the parahisian accessory pathways (PHAP) has been established as the definitive therapy for this type of arrhythmia. However, the PHAP proximity to the normal atrioventricular conduction system makes the procedure technically challenging.Here, we have reported a case series of 20 patients with PHAP who underwent aortic access ablation to evaluate the safety and efficacy of this approach in the PHAP ablation.Methods and Results: The ablation through the aortic cusps was the successful approach in 13 of 20 (65%) of the cases. In 11 patients, the aortic approach was the initial strategy for ablation, and the accessory pathway was eliminated in seven (63.6%) of them. The aortic approach followed a failed right‐sided attempt in nine patients. In six (66.7%) patients, the ablation was successful with the aortic approach.The only independent predictor for the successful ablation with each approach was the earliest ventricular activation before delta wave (predelta time) and a right‐sided earliest ventricular activation of more than 23 ms had high sensitivity and specificity for right‐sided success.Systematically using the two strategies (right and left approaches), the ablation of the PHAP was successful in 18 (90%) patients.Conclusion: The aortic approach seems to be a safe and effective strategy for the ablation of PHAP. It can be used when the right‐sided approach fails or even considered as an initial strategy when the predelta time is less than 23 ms in the right septal region. When combining the right‐ and left‐sided approaches, the success rate is high. We believe that the retrograde aortic approach remains a key tool for this challenging ablation.
- 16 April 2020
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 31 (6) , 1413-1419
Catheter ablation of the parahisian accessory pathways from the aortic cusps—Experience of 20 cases—Improving the mapping strategy for better results
Introduction: Catheter ablation of the parahisian accessory pathways (PHAP) has been established as the definitive therapy for this type of arrhythmia. However, the PHAP proximity to the normal atrioventricular conduction system makes the procedure technically challenging.Here, we have reported a case series of 20 patients with PHAP who underwent aortic access ablation to evaluate the safety and efficacy of this approach in the PHAP ablation.Methods and Results: The ablation through the aortic cusps was the successful approach in 13 of 20 (65%) of the cases. In 11 patients, the aortic approach was the initial strategy for ablation, and the accessory pathway was eliminated in seven (63.6%) of them. The aortic approach followed a failed right‐sided attempt in nine patients. In six (66.7%) patients, the ablation was successful with the aortic approach.The only independent predictor for the successful ablation with each approach was the earliest ventricular activation before delta wave (predelta time) and a right‐sided earliest ventricular activation of more than 23 ms had high sensitivity and specificity for right‐sided success.Systematically using the two strategies (right and left approaches), the ablation of the PHAP was successful in 18 (90%) patients.Conclusion: The aortic approach seems to be a safe and effective strategy for the ablation of PHAP. It can be used when the right‐sided approach fails or even considered as an initial strategy when the predelta time is less than 23 ms in the right septal region. When combining the right‐ and left‐sided approaches, the success rate is high. We believe that the retrograde aortic approach remains a key tool for this challenging ablation.